Courtesy of Kiarash Sabet/UCLA
UCLA-developed handheld diagnostic lab kit capable of fully automated multiplexed and pooled testing
Cost-saving advance can fully automate pooled testing and detect multiple diseases
Using swarms of pinhead-sized magnets inside a handheld, all-in-one lab kit, UCLA researchers have developed a technology that could significantly increase the speed and volume of disease testing, while reducing the costs and usage of scarce supplies.
The automated tests can be easily manufactured, deployed and performed timely at a doctor’s office, health clinic or at mass testing sites in airports and schools at the onset of any major infectious disease. The UCLA-led research team was motivated by the lack of equitable access to testing during the early months of the COVID-19 pandemic when only a handful of clinical laboratories were authorized to run tests. The technology breakthrough could help the authorities better prepare for future pandemics by decentralizing testing and maximizing the use of resources.
UCLA Samueli School of Engineering professor Dino Di Carlo of bioengineering and associate professor Sam Emaminejad of electrical and computer engineering co-authored a study, which was published this week in Nature. The paper outlined how the lab kit works and included findings from a clinical study with test samples from individuals who experienced COVID-19 symptoms. More than 100 test results using the lab kit were compared to the same samples tested for COVID-19 using polymerase chain reaction (PCR)-based molecular diagnostics performed as part of UCLA Health’s routine clinical care.
“Our handheld lab technology could help overcome some of the barriers of scarcity and access to tests, especially early in a pandemic, when it is most crucial to control disease spread,” said Emaminejad, who also holds a faculty appointment in bioengineering. “And beyond its potential to address issues of short supplies and high demand, it could be broadly adapted to test for many types of diseases in field and with lab-grade quality.”
Using a circuit board that controls a set of movable, 1-millimeter-sized magnetic discs known as “ferrobots” to transport samples through the diagnostic workflow of a nucleic acid amplification test (NAAT), the researchers’ ultra-sensitive lab kit was able to detect the presence of genetic material from a virus — in this case, SARS-CoV-2 that causes COVID-19. The steps to separate, sort, mix and amplify testing samples are all automated and performed at a miniaturized level inside the kit.
“This platform’s compact design and automated handling of samples enable easy implementations of pooled testing where you can test dozens of patient samples at the same time, and all with the same materials it currently takes to test just one patient,” said Di Carlo, who holds UCLA’s Armond and Elena Hairapetian Chair in Engineering and Medicine. “For example, you could test students in an entire college residence hall with just a few dozen test kits.”
By designing the kit for pooled testing, the system requires much lower amounts of reagent chemicals than those needed for testing the samples individually. Up to 16 samples were combined and tested at once in the team’s study. If the pooled test showed a positive result, subsequent tests would automatically take place within the same platform until the actual positive samples were identified. This entire process took between 30 to 60 minutes, depending on whether there were positive samples. Thanks to the technology’s assay miniaturization and pooled-testing capabilities, the chemical reagent costs could be reduced by 10 to 300 times.
Aside from being able to test for several diseases simultaneously, the platform also offers precision and robust automation. For example, in a pooled-testing with 16 samples, more than 300 lab operations, including mixing and sorting, were automated by the ferrobots — that is more than 3,000 individual movements, or actuations. In their reliability studies, the researchers showed that the ferrobots could perform more than 8 million actuations without mistakes.
Original Article: Handheld Diagnostic Lab Offers Point-of-Care Solution for Future Pandemics
More from: UCLA Henry Samueli School of Engineering and Applied Science | University of California Los Angeles
The Latest Updates from Bing
Go deeper with Bing News on:
Disease diagnostic tool
- Embiid's diagnosis draws new attention to Bell's palsy
Philadelphia 76ers All-Star center Joel Embiid has been diagnosed with Bell's palsy. A facial nerve gets inflamed or injured and suddenly muscles on one side of the face become weak or paralyzed.
- AI System Unveils New Approach to Rare Disease Diagnosis
Investigators at Baylor College of Medicine developed a new AI system called AI-MARRVEL (AIM) that helps doctors diagnose rare genetic diseases more quickly and accurately. The research was published ...
- Scientists discover potential biomarkers of environmental exposures in Parkinson's disease
A team of Northwestern Medicine investigators has discovered novel DNA methylation patterns in the blood of patients with Parkinson's disease, according to findings published in Annals of Neurology.
- Novant Health to add AI tools to speed up diagnosis and treatment of lung disease
For example, radiology charts used in AI programs in urban areas will have a different make-up when compared to rural America.
- AI tool recognizes serious ocular disease in horses
Colloquially known as moon blindness, equine recurrent uveitis (ERU) is an inflammatory ocular disease in horses, which can lead to blindness or loss of the affected eye. It is one of the most common ...
Go deeper with Bing News on:
Decentralizing disease testing
- Malaria parasites can evade rapid tests, threatening eradication goals
Genetic mutations are making Plasmodium falciparum, parasites that cause malaria, invisible to rapid tests. New, more sensitive tests could help.
- Prioritising post-testing healthcare for disease sufferers
It appears that people who are inclined to ‘hide’ or ‘disappear’ after testing positive for a high-profile disease in Nigeria are often left like that with no serious efforts to follow ...
- New Inflammatory Bowel Disease testing protocol could speed up diagnosis
Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that would reduce the need and lengthy wait for potentially unnecessary colonoscopies, a new study ...
- New inflammatory bowel disease testing protocol could speed up diagnosis
Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that would reduce the need and lengthy wait for potentially unnecessary colonoscopies ...
- Hypertensive Heart Disease
If you do have high blood pressure, take extra care to look out for symptoms of heart disease. Your doctor will review your medical history, conduct a physical exam, and run lab tests to check ...